Lise L. Holm
Odense, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Oligonucleotides targeting the 3' splice site downstream of a microexon as an innovative therapy for autism.
Journal: NAR molecular medicine
Published: November 27, 2024
Regulating PCCA gene expression by modulation of pseudoexon splicing patterns to rescue enzyme activity in propionic acidemia.
Journal: Molecular therapy. Nucleic acids
Published: July 10, 2023
All exons are not created equal-exon vulnerability determines the effect of exonic mutations on splicing.
Journal: Nucleic acids research
Published: July 07, 2023
Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene.
Journal: Nucleic acid therapeutics
Published: July 14, 2022
Topoisomerase 1 inhibits MYC promoter activity by inducing G-quadruplex formation.
Journal: Nucleic acids research
Published: January 28, 2022
Vulnerable exons, like ACADM exon 5, are highly dependent on maintaining a correct balance between splicing enhancers and silencers.
Journal: Human mutation
Published: September 25, 2021
Identification of SRSF10 as a regulator of SMN2 ISS-N1.
Journal: Human mutation
Published: March 26, 2020
DeepCLIP: predicting the effect of mutations on protein-RNA binding with deep learning.
Journal: Nucleic acids research
Published: October 23, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026